UBS Group’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $713K | Sell |
98,978
-812,431
| -89% | -$5.22M | ﹤0.01% | 5814 |
|
|
2025
Q4 | $5.14M | Buy |
911,409
+187,264
| +26% | +$1.01M | ﹤0.01% | 4001 |
|
|
2025
Q3 | $4.47M | Sell |
724,145
-48,150
| -6% | -$282K | ﹤0.01% | 4148 |
|
|
2025
Q2 | $3.76M | Buy |
772,295
+657,600
| +573% | +$2.32M | ﹤0.01% | 4167 |
|
|
2025
Q1 | $424K | Buy |
114,695
+20,228
| +21% | +$86.6K | ﹤0.01% | 5978 |
|
|
2024
Q4 | $378K | Buy |
94,467
+82,471
| +687% | +$453K | ﹤0.01% | 6040 |
|
|
2024
Q3 | $83.6K | Buy |
11,996
+5,126
| +75% | +$41.6K | ﹤0.01% | 6478 |
|
|
2024
Q2 | $39K | Sell |
6,870
-7,379
| -52% | -$66.1K | ﹤0.01% | 6882 |
|
|
2024
Q1 | $190K | Buy |
14,249
+10,225
| +254% | +$95.7K | ﹤0.01% | 5888 |
|
|
2023
Q4 | $24.7K | Buy |
4,024
+4,009
| +26,727% | +$12.8K | ﹤0.01% | 6974 |
|
|
2023
Q3 | $38 | Sell |
15
-178
| -92% | -$690 | ﹤0.01% | 9048 |
|
|
2023
Q2 | $1.01K | Buy |
193
+27
| +16% | +$152 | ﹤0.01% | 8037 |
|
|
2023
Q1 | $787 | Hold |
166
| – | – | ﹤0.01% | 8904 |
|
|
2022
Q4 | $893 | Sell |
166
-1
| -0.6% | -$7 | ﹤0.01% | 10042 |
|
|
2022
Q3 | $1K | Hold |
167
| – | – | ﹤0.01% | 10027 |
|
|
2022
Q2 | $2K | Hold |
167
| – | – | ﹤0.01% | 9609 |
|
|
2022
Q1 | $3K | Sell |
167
-2,600
| -94% | -$45.9K | ﹤0.01% | 9478 |
|
|
2021
Q4 | $72K | Buy |
2,767
+2,360
| +580% | +$72.1K | ﹤0.01% | 6600 |
|
|
2021
Q3 | $15K | Buy |
407
+55
| +16% | +$2.34K | ﹤0.01% | 7516 |
|
|
2021
Q2 | $19K | Sell |
352
-439
| -55% | -$29K | ﹤0.01% | 7395 |
|
|
2021
Q1 | $66K | Sell |
791
-270
| -25% | -$29.9K | ﹤0.01% | 6285 |
|
|
2020
Q4 | $121K | Buy |
1,061
+883
| +496% | +$55.8K | ﹤0.01% | 5564 |
|
|
2020
Q3 | $5K | Sell |
178
-748
| -81% | -$28.6K | ﹤0.01% | 7336 |
|
|
2020
Q2 | $40K | Sell |
926
-3,028
| -77% | -$126K | ﹤0.01% | 6067 |
|
|
2020
Q1 | $141K | Sell |
3,954
-1,094
| -22% | -$54.1K | ﹤0.01% | 4995 |
|
|
2019
Q4 | $337K | Sell |
5,048
-377
| -7% | -$41.6K | ﹤0.01% | 5192 |
|
|
2019
Q3 | $842K | Buy |
5,425
+2,747
| +103% | +$311K | ﹤0.01% | 4106 |
|
|
2019
Q2 | $231K | Sell |
2,678
-270
| -9% | -$29.4K | ﹤0.01% | 4828 |
|
|
2019
Q1 | $407K | Sell |
2,948
-4,889
| -62% | -$1.22M | ﹤0.01% | 4182 |
|
|
2018
Q4 | $3.15M | Buy |
7,837
+4,642
| +145% | +$2.18M | ﹤0.01% | 2588 |
|
|
2018
Q3 | $2.26M | Buy |
3,195
+503
| +19% | +$316K | ﹤0.01% | 3115 |
|
|
2018
Q2 | $1.44M | Buy |
2,692
+1,973
| +274% | +$607K | ﹤0.01% | 3460 |
|
|
2018
Q1 | $81K | Buy |
+719
| New | +$243K | ﹤0.01% | 5365 |
|
Other funds holding SLDB
PA
BCLSI
RCM
SL
VPC
DTC
AC